Stay updated with breaking news from Pharma Partnering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Basel, 27 May 2024 - Roche announced today that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head...
Basel, 27 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry
Roche announced that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head of Genentech Partnering. In...
The new blockbuster paper by the St Gallen consortium reveals the efficiency pharmaceutical R&D. The majority of the approved drugs were sourced externally.
LEXINGTON, Mass.--(BUSINESS WIRE)--KSQ Therapeutics, Inc. (“KSQ”), a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, announced today it has entered into a worldwide license and collaboration agreement with Roche for the development and commercia...